Literature DB >> 14604776

Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains.

Patrick M Connolly1, Christina R Maxwell, Stephen J Kanes, Ted Abel, Yuling Liang, Jan Tokarczyk, Warren B Bilker, Bruce I Turetsky, Raquel E Gur, Steven J Siegel.   

Abstract

Previous data have shown differences among inbred mouse strains in sensory gating of auditory evoked potentials, prepulse inhibition (PPI) of startle, and startle amplitude. These measures of sensory and sensorimotor gating have both been proposed as models for genetic determinants of sensory processing abnormalities in patients with schizophrenia and their first-degree relatives. Data from our laboratory suggest that auditory evoked potentials of DBA/2J mice differ from those previously described for DBA/2Hsd. Therefore, we compared evoked potentials and PPI in these two closely related substrains based on the hypothesis that any observed endophenotypic differences are more likely to distinguish relevant from incidental genetic heterogeneity than similar approaches using inbred strains that vary across the entire genome. We found that DBA/2Hsd substrain exhibited reduced inhibition of evoked potentials and reduced startle relative to the DBA/2J substrain without alterations in auditory sensitivity, amplitude of evoked potentials or PPI of startle. These results suggest that gating of auditory evoked potentials and PPI of startle measure different aspects of neuronal function. The differences between the substrains might reflect genetic drift. Alternatively, differences could arise from different rearing environments or other non-genetic factors. Future studies will attempt to determine the cause of these differences in sensory and sensorimotor processing between these two closely related inbred mouse strains.

Entities:  

Mesh:

Year:  2003        PMID: 14604776     DOI: 10.1016/j.brainres.2003.08.035

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?

Authors:  M J Gandal; R L Anderson; E N Billingslea; G C Carlson; T P L Roberts; S J Siegel
Journal:  Genes Brain Behav       Date:  2012-08       Impact factor: 3.449

2.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

3.  Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients.

Authors:  C R Maxwell; Y Liang; M P Kelly; S J Kanes; T Abel; S J Siegel
Journal:  Neuroscience       Date:  2006-06-05       Impact factor: 3.590

Review 4.  Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.

Authors:  D Sinclair; B Oranje; K A Razak; S J Siegel; S Schmid
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

5.  NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia.

Authors:  John A Saunders; Michael J Gandal; Steve J Siegel
Journal:  Neurobiol Dis       Date:  2012-01-09       Impact factor: 5.996

6.  MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder.

Authors:  Wenlin Liao; Michael J Gandal; Richard S Ehrlichman; Steven J Siegel; Greg C Carlson
Journal:  Neurobiol Dis       Date:  2012-01-09       Impact factor: 5.996

7.  Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors.

Authors:  Kenji Hashimoto; Masaomi Iyo; Robert Freedman; Karen E Stevens
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

8.  Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia.

Authors:  Gregory C Carlson; Konrad Talbot; Tobias B Halene; Michael J Gandal; Hala A Kazi; Laura Schlosser; Quan H Phung; Raquel E Gur; Steven E Arnold; Steven J Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

9.  Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice.

Authors:  Christina L Bodarky; Tobias B Halene; Richard S Ehrlichman; Anamika Banerjee; Rabindranath Ray; Chang-Gyu Hahn; Gerald Jonak; Steven J Siegel
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

10.  The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components.

Authors:  Patrick M Connolly; Christina Maxwell; Yuling Liang; Jonathan B Kahn; Stephen J Kanes; Ted Abel; Raquel E Gur; Bruce I Turetsky; Steven J Siegel
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.